Phase I study of stereotactic body radiation therapy for centrally located stage IA non-small cell lung cancer (JROSG10-1)-Reference-Cited by-同舟云学术

Phase I study of stereotactic body radiation therapy for centrally located stage IA non-small cell lung cancer (JROSG10-1)

Published:2017-05-02 Issue:5 Volume:22 Page:849-856
ISSN:1341-9625
Container-title:International Journal of Clinical Oncology
language:en
Short-container-title:Int J Clin Oncol

Author:

Kimura Tomoki^ORCID,Nagata Yasushi,Harada Hideyuki,Hayashi Shinya,Matsuo Yukinori,Takanaka Tsuyoshi,Kokubo Masaki,Takayama Kenji,Onishi Hiroshi,Hirakawa Koichi,Shioyama Yoshiyuki,Ehara Takeshi

Funder

Japanese Radiation Oncology Study Group (JROSG)

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Hematology,General Medicine,Surgery

Link

http://link.springer.com/article/10.1007/s10147-017-1125-y/fulltext.html

Reference23 articles.

1. Onishi H, Shirato H, Nagata Y et al (2007) Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small-cell lung cancer: updated results of 257 patients in Japanese multi-institutional study. J Thorac Oncol 2(Suppl 3):S94–S100

2. Takeda A, Sanuki N, Kunieda E et al (2009) Stereotactic body radiotherapy for primary lung cancer at a dose of 50 Gy total in five fractions to the periphery of the planning target volume calculated using a superposition algorithm. Int J Radiat Oncol Biol Phys 73:442–448

3. Nagata Y, Hiraoka M, Shibata T et al (2015) Prospective trial of stereotactic body radiation therapy for both operable and inoperable T1N0M0 non-small cell lung cancer: Japan Clinical Oncology Group Study JCOG0403. Int J Radiat Oncol Biol Phys 93:989–996

4. Timmerman R, Rebecca P, Galvin J et al (2010) Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 303:1070–1076

5. Baumann P, Nyman J, Hoyer M et al (2009) Outcome in a prospective phase II trial of medically inoperable stage I non-small cell lung cancer patients treated with stereotactic body radiotherapy. JCO 27:3290–3296

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential Role of Lymphocyte CD44 in Determining Treatment Selection Between Stereotactic Body Radiation Therapy and Surgery for Early-Stage Non-Small Cell Lung Cancer;International Journal of Radiation Oncology*Biology*Physics;2024-09

2. Protocol of a phase II study to evaluate the efficacy and safety of deep-inspiration breath-hold daily online adaptive radiotherapy for centrally located lung tumours (PUDDING study);Radiation Oncology;2024-03-08

3. Biomedical advances and future prospects of high-precision three-dimensional radiotherapy and four-dimensional radiotherapy;Proceedings of the Japan Academy, Series B;2023-11-10

4. Mathematical model combined with microdosimetric kinetic model for tumor volume calculation in stereotactic body radiation therapy;Scientific Reports;2023-07-06

5. Long-term Outcomes After Moderate Hypofractionated Proton Therapy for Centrally Located Non-small Cell Lung Cancer;Anticancer Research;2023-04-25